Alpha Tau Medical
DRTS
21 hedge funds and large institutions have $3.03M invested in Alpha Tau Medical in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.
186% more capital inflows, than outflows
Capital inflows: $159K | Capital outflows: $55.4K
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
0.04% more ownership
Funds ownership: 1.36% → 1.4% (+0.04%)
9% less funds holding
Funds holding: 23 → 21 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$68.6K |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$66K |
| 3 |
Levin Capital Strategies
New York
|
+$18.4K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$5.57K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$38.8K |
| 2 |
Steward Partners Investment Advisory
New York
|
-$6.4K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$4K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$2.84K |
| 5 |
Tuttle Capital Management
Riverside,
Connecticut
|
-$2.38K |
DRTS Hedge Fund Activity: Q4 2024 in Review
21 of the 7,617 institutional investors tracked by Wall St. Rank reported a position in Alpha Tau Medical (DRTS) for Q4 2024, worth a combined $3.03M — up 36% from $2.23M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of DRTS and 1 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 4 added.
The largest buyer was Renaissance Technologies, adding an estimated $68.6K. The largest seller was Citadel Advisors, exiting entirely with an estimated $38.8K sold.
- 21 institutional investors held Alpha Tau Medical (DRTS) as of Q4 2024, down from 23 in Q3 2024.
- Funds reported $3.03M of Alpha Tau Medical stock for Q4 2024, up 36% quarter-over-quarter.
- 1 fund opened new Alpha Tau Medical positions in Q4 2024 and 3 closed out, a net change of -2 holders.
- The largest Alpha Tau Medical buyer in Q4 2024 was Renaissance Technologies, an estimated $68.6K added.
- The largest Alpha Tau Medical seller in Q4 2024 was Citadel Advisors, an estimated $38.8K sold.
Based on aggregated 13F filings for Q4 2024.